DRUG · Unmapped registry intervention
SPD489 (Lisdexamfetamine dimesylate)
Find medicine records ·
Find other trials using this name
Clinical trial
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
NCT00985725
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Matching placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Shirelead sponsor
Mapped research locations
HoustonTexas, United States2JacksonvilleFlorida, United States2DallasTexas, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1CincinnatiOhio, United States1DurhamNorth Carolina, United States1OrlandoFlorida, United States1Chapel HillNorth Carolina, United States1RaleighNorth Carolina, United States1LincolnNebraska, United States1Overland ParkKansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00985725 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.